Prashant Maheshwari*, Pooja Agarwal, Virendra Kushwaha, Ambrish Gupta, B. P. Priyadarshi and Tanu Midha


Objective: To study the pattern of Anaemia due to different anti-retroviral regimens in HIV/AIDS patients. Material & Methods: A prospective observational study was conducted over a period of fifteen months at ART Centre, GSVM Medical College Kanpur. All HIV positive patients attending O.P.D. who encountered ADRs were enrolled in our study irrespective to their age and sex. Data was collected using ADR reporting form issued by Indian Pharmacopoeia Commission. Causality assessment was done by using Naranjo’s Probability Scale. Modified Hartwig severity scale was used to evaluate severity, WHO criteria for seriousness and guidelines of council for international organizations of medical sciences to decide the predictability of ADRs. Results: A total no of 250 patients encountered various types of ADRs during our study period i.e. January 2015 to March 2016. Total number of ADRs recorded was 452. Out of total ADRs recorded 131 ADRs were anaemia. Maximum burden of anaemia was found in the patients who were on zidovudine based regimen. CD4 count <250 cells/mm3 was observed as a risk factor for development of anaemia. On severity scale most of the cases of anaemia were found to be of mild type. Conclusion: Almost every anti-retroviral drug is associated with anaemia but incidence is maximum with zidovudine containing regimens. So clinician should prescribe tenofovir based first line anti-retroviral regimen whenever possible as tenofovir has less adverse drug reactions especially anaemia in comparision to zidovudine and recently WHO also recommended that tenofovir based regimen should be preferred as first line regimen.

Keywords: HIV, Anti-Retroviral Therapy, Adverse Drug Reaction, Anaemia.

[Full Text Article]   [Download Certificate]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MAY 2024 Issue has been successfully launched on 1 MAY 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction